The Balancing Act ® Airing on Lifetime TV Goes Behind the Mystery of Alpha-1

ImagePompano Beach, FL – Popular morning show The Balancing Act® airing on Lifetime® TV welcomes CSL Behring, a company that manufactures biotherapies to treat rare conditions, to the show airing on Tuesday, November 5th at 7:00am (ET/PT). CSL Behring is part of the “Behind the Mystery: Rare and Genetic Diseases” programming. Make sure to tune in as The Balancing Act hosts help jump start the day with animated conversation and trusted information to empower a woman´s life.

Don´t miss this featured segment taking center stage on The Balancing Act®.

– Go Behind the Mystery of Alpha-1 with CSL Behring

Learn about a lung disease known as “Alpha-1” that is commonly misdiagnosed as COPD, asthma and/or emphysema and often takes up to 7 years and multiple physicians to accurately diagnose. Join Dr. Robert Sandhaus, Director of the Alpha-1 Program at the National Jewish Health Center in Denver, as he talks about Alpha-1 (Antitrypsin Deficiency), explaining why this disease is so often misdiagnosed, and a simple way to test for it; along with a patient who shares her story. Alpha-1 Testing is now more readily available as CSL Behring offers advanced testing resources.

“The Balancing Act provided us with a unique opportunity to reach viewers who may be diagnosed, or may know someone who is diagnosed with COPD, Emphysema, or Asthma. This program has allowed us to increase our efforts on making Alpha-1 more publicly known.”

About The Balancing Act® on Lifetime Television

Now in its 6th year, The Balancing Act® continues to empower women in all aspects of their lives. The mission at The Balancing Act® is simple – the show strives to help today`s modern woman balance it all by bringing them exceptional solutions to everyday problems. Entertaining, educational, and trusted by women, viewers can tune in to America´s premier morning show The Balancing Act on weekday mornings at 7:00am (ET/PT) on Lifetime television.

For additional information or to view the segment visit:

Media Contact

O2Media, Inc.

Source: CSL Behring

We welcome a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s